SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Hagman Helga)
 

Search: WFRF:(Hagman Helga) > (2019) > Clinical impact of ...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Clinical impact of peripherally inserted central catheters vs implanted port catheters in patients with cancer : an open-label, randomised, two-centre trial

Taxbro, Knut (author)
Linköpings universitet,Avdelningen för läkemedelsforskning,Medicinska fakulteten,Ryhov Cty Hosp, Sweden
Hammarskjöld, Fredrik (author)
Linköpings universitet,Avdelningen för mikrobiologi, infektion och inflammation,Medicinska fakulteten,Ryhov Cty Hosp, Sweden
Thelin, Bo (author)
Ryhov Cty Hosp, Sweden
show more...
Lewin, Freddi (author)
Ryhov Cty Hosp, Sweden
Hagman, Helga (author)
Skane Univ Hosp, Sweden
Hanberger, Håkan (author)
Linköpings universitet,Avdelningen för mikrobiologi, infektion och inflammation,Medicinska fakulteten,Region Östergötland, Infektionskliniken i Östergötland
Berg, Sören (author)
Linköpings universitet,Avdelningen för kardiovaskulär medicin,Medicinska fakulteten,Region Östergötland, Thorax-kärlkliniken i Östergötland
show less...
 (creator_code:org_t)
Elsevier, 2019
2019
English.
In: British Journal of Anaesthesia. - : Elsevier. - 0007-0912 .- 1471-6771. ; 122:6, s. 734-741
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • BackgroundCentrally inserted totally implanted vascular access ports (PORTs) and peripherally inserted central catheters (PICCs) are widely used for the administration of chemotherapy. Our aim was to study the incidence of catheter-related deep venous thrombosis in patients with cancer receiving chemotherapy through either a PICC or a PORT.MethodsAdults with non-haematological cancer (mainly breast and colorectal) from two Swedish oncology centres were included and followed for up to 1 yr. Patients were randomly assigned to receive a single-lumen PICC or PORT. The primary end point was the occurrence of a clinically significant catheter-related deep venous thrombosis, and the secondary end point was a composite of adverse events related to the catheter: insertion complication, thrombosis, occlusion, infection, and mechanical problems.ResultsThe trial recruited 399 participants (PICC, n=201; PORT, n=198) between March 2013 and February 2017. The PICCs were associated with 16 (8%) deep venous thromboses compared with two (1%) in the PORT group (HR=10.2; 95% confidence interval, 2.3–44.6; P=0.002). The overall incidence of composite adverse events was higher for patients with a PICC compared with those with a PORT (HR=2.7; 95% confidence interval, 1.6–4.6; P<0.001).ConclusionsPICCs are associated with higher risk for catheter-related deep venous thrombosis and other adverse events when compared with PORTs. This increased risk should be considered when choosing a vascular access device for chemotherapy, especially in patients with solid malignancy.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Kirurgi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Surgery (hsv//eng)

Keyword

central venous catheter; central venous catheter thrombosis; peripherally inserted central catheter line insertion; vascular access devices

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view